A short teaser points to another reported side effect of GLP-1 drugs but doesn't say what it is.
Recap by typeshit. Post by Facebook on Facebook.
Disposable pens for insulin, MS and weight loss drugs are reaching recycling centres, where workers could come into contact with them.
Martin cautions followers that peptides being simpler to obtain is no reason to use ones that haven't been tested much.
BuzzFeed's celebrity desk picks up a widely viewed post joking about a new GLP-1 side effect, following slang like Ozempic face. Details are thin.
He says shedding tied to GLP-1 drugs usually passes, but can linger, and points to telogen effluvium triggered by fast weight loss.
Lilly says participants lost 44 to 47 pounds versus about 21 on Ozempic, with bigger A1C drops. It plans to file for approval in 2027.
Lilly reports people on retatrutide lost 44 to 47 pounds over 80 weeks versus about 21 on Ozempic. It plans to file for approval in 2027.
Loading…